Summary
Stryker Corporation announced a significant development through an 8-K filing on November 5, 2019, detailing a definitive agreement to acquire Wright Medical Group N.V. The acquisition will be initiated via a tender offer by Stryker's subsidiary, Stryker B.V., to purchase all outstanding ordinary shares of Wright Medical for $30.75 per share in cash. This move signals Stryker's intent to bolster its position in the medical technology market, particularly in areas where Wright Medical has a strong presence. The transaction is not contingent on financing, which is a positive indicator for deal certainty.
Key Highlights
- 1Stryker to acquire Wright Medical Group N.V. via a tender offer for $30.75 per share in cash.
- 2The acquisition is being pursued by Stryker B.V., a wholly-owned subsidiary of Stryker.
- 3The tender offer is conditional on at least 80% (potentially 95% or reduced by Stryker) of Wright Medical shares being tendered, along with regulatory approvals.
- 4The transaction is not subject to a financing condition, increasing deal certainty.
- 5Following the tender offer, Stryker may complete the acquisition through a Post-Offer Reorganization, which could involve mergers, asset sales, or a compulsory acquisition process.
- 6Customary representations, warranties, and covenants are included in the Purchase Agreement, with Wright Medical agreeing to operate its business in the ordinary course.
- 7Wright Medical may be required to pay a termination fee of $150 million under certain circumstances.